VIDEO: US Senate Panel — Jan 24, 2022
US Senate Panel Jan 24, 2022 comments by critical care experts Drs. Kory and Marik, and Jennifer Bridges, RN, on inpatient therapeutics aimed to work at the antiviral stages. Two of them are oral and also have anti-inflammatory effects, hence their widespread use worldwide.
The doctors said that Remdesivir costs about $3,000 a course and increases the risk of death whereas Ivermectin reduces the risk of death by about 50% and it costs the World Health Organisation about 2 cents per tablet.